D'Angelica M, Are C, Jarnagin W, DeGregoris G, Coit D, Jaques D, Brennan M, Fong Y
Department of Surgery, Memorial Sloan Kettering Cancer Centre, USA.
Surg Endosc. 2006 Jan;20(1):142-8. doi: 10.1007/s00464-005-0209-3. Epub 2005 Dec 7.
Hand-assisted laparoscopic distal pancreatectomy, with or without splenectomy, is gradually gaining acceptance, although its ultimate benefit is yet to be confirmed. This study aimed to report our initial experience with hand-assisted laparoscopic distal pancreatectomy.
A retrospective review of a prospectively collected database including 17 patients during the period 2002-2004 was conducted. The median age was 60 years (range, 29-85 years), and the female-to-male ratio was 13:4. The preoperative diagnoses included benign and malignant conditions. Besides two to three ports, a hand port was placed in the upper midline to aid in dissection. The pancreas was divided with a stapler in all the patients, and drains were placed in 10 patients (70%).
One patient was found to be unresectable because of celiac artery involvement, and 2 of the remaining 16 patients underwent conversion to an open procedure. The median operating time was 196 min (range, 128-235 min). The mean tumor size was 4 cm (range, 2-7 cm), and the estimated blood loss was 125 ml (range, 50-1,250 ml). The median time to resumption of a regular diet was 3.5 days (range, 2-9 days), and the time to conversion to oral pain medications was 3 days (range, 2-9 days). The length of hospital stay was 5.5 days (range, 4-18 days), with a majority of the patients (11 patients, 78%) staying less than 7 days. There were no mortalities. The overall postoperative morbidity rate was 25%, and the morbidities consisted of pancreatic leak/fistula (2 patients, 14%) and fever (1 patient). The margins were negative in 10 (76%) of the relevant 13 patients. At a median follow-up period of 3.8 months (range, 5-14 months), 11 (84%) of 13 patients had no evidence of disease recurrence.
The minimally invasive approach to pancreatic disease is safe and technically feasible. Further large studies with longer follow-up periods are necessary to determine the role of laparoscopic surgery in the management of pancreatic disease.
手辅助腹腔镜远端胰腺切除术,无论是否行脾切除术,正逐渐被接受,尽管其最终益处尚未得到证实。本研究旨在报告我们在手辅助腹腔镜远端胰腺切除术方面的初步经验。
对一个前瞻性收集的数据库进行回顾性分析,该数据库纳入了2002年至2004年期间的17例患者。中位年龄为60岁(范围29 - 85岁),男女比例为13:4。术前诊断包括良性和恶性疾病。除了两到三个操作孔外,在上腹部中线处放置一个手辅助孔以协助解剖。所有患者均使用吻合器离断胰腺,10例患者(70%)放置了引流管。
1例患者因腹腔干受累而无法切除,其余16例患者中有2例转为开放手术。中位手术时间为196分钟(范围128 - 235分钟)。平均肿瘤大小为4厘米(范围2 - 7厘米),估计失血量为125毫升(范围50 - 1250毫升)。恢复正常饮食的中位时间为3.5天(范围2 - 9天),改用口服止痛药物的时间为3天(范围2 - 9天)。住院时间为5.5天(范围4 - 18天),大多数患者(11例,78%)住院时间少于7天。无死亡病例。总体术后发病率为25%,并发症包括胰漏/胰瘘(2例,14%)和发热(1例)。13例相关患者中有10例(76%)切缘阴性。中位随访期为3.8个月(范围5 - 14个月),13例患者中有11例(84%)无疾病复发迹象。
胰腺疾病的微创治疗方法是安全且技术上可行的。需要进一步开展长期随访的大型研究来确定腹腔镜手术在胰腺疾病治疗中的作用。